Dr. Mark Cunningham, MD
Claim this profileUniversity of Southern California University Hospital
Studies Mitral Regurgitation
Studies Mitral Valve Regurgitation
5 reported clinical trials
7 drugs studied
Affiliated Hospitals
Clinical Trials Mark Cunningham, MD is currently running
TMVR
for Mitral Valve Regurgitation
Multi-center, global, prospective, non-randomized, interventional, pre-market trial. All subjects enrolled with receive the study device.
Recruiting1 award N/A
Percutaneous vs Surgical Repair
for Mitral Valve Regurgitation
This is a prospective, multicenter, open-label, randomized trial comparing mitral valve (MV) transcatheter edge-to-edge repair (TEER) to surgical repair (1:1 ratio) in patients with primary, degenerative mitral regurgitation (MR). The trial will be conducted in the U.S., Canada, Germany and the United Kingdom, and is designed as a strategy trial. Thus, all devices legally marketed for TEER of primary degenerative MR in a particular country are eligible to be used in this trial.
Recruiting1 award N/A5 criteria
More about Mark Cunningham, MD
Clinical Trial Related7 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Mark Cunningham, MD has experience with
- MitraClip System
- Tendyne Mitral Valve System
- HARPOON™ Beating Heart Mitral Valve Repair System
- Valve-in-Valve Treatment
- Mitral Valve Repair
- TEER
Breakdown of trials Mark Cunningham, MD has run
Mitral Regurgitation
Mitral Valve Regurgitation
Sleep Apnea and Cardiovascular Disease
Heart Valve Disease
Cardiovascular Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark Cunningham, MD specialize in?
Mark Cunningham, MD focuses on Mitral Regurgitation and Mitral Valve Regurgitation. In particular, much of their work with Mitral Regurgitation has involved treating patients, or patients who are undergoing treatment.
Is Mark Cunningham, MD currently recruiting for clinical trials?
Yes, Mark Cunningham, MD is currently recruiting for 3 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Mark Cunningham, MD has studied deeply?
Yes, Mark Cunningham, MD has studied treatments such as MitraClip System, Tendyne Mitral Valve System, HARPOON™ Beating Heart Mitral Valve Repair System.
What is the best way to schedule an appointment with Mark Cunningham, MD?
Apply for one of the trials that Mark Cunningham, MD is conducting.
What is the office address of Mark Cunningham, MD?
The office of Mark Cunningham, MD is located at: University of Southern California University Hospital, Los Angeles, California 90033 United States. This is the address for their practice at the University of Southern California University Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.